E. Fujii et al., ROLE OF NITRIC-OXIDE, PROSTAGLANDINS AND TYROSINE KINASE IN VASCULAR ENDOTHELIAL GROWTH FACTOR-INDUCED INCREASE IN VASCULAR-PERMEABILITY INMOUSE SKIN, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 475-480
We investigated role of nitric oxide (NO), prostaglandins (PG) and tyr
osine kinase in vascular endothelial growth factor (VEGF)-induced incr
ease in vascular permeability in mouse skin. Subcutaneous injection of
VEGF (0.5-2.0 ng/site) induced dose-and time-dependent increase in va
scular permeability at the injection site determined by a leakage of P
ontamine sky blue. VEGF (1 ng/site)-induced dye leakage was partially
inhibited by NG-nitro-L-arginine methyl ester (an inhibitor for both c
onstitutive and inducible NO synthase) (5 and 10 mg/kg, i.v.) and by a
minoguanidine (a selective inducible NO synthase inhibitor) (5-20 mg/k
g, i.v.), but not by an inactive enantiomer, N-G-nitro-D-arginine meth
yl ester (10 mg/kg, i.v.). Pretreatment with an intraperitoneal inject
ion of indomethacin (a nonselective cyclooxygenase inhibitor) (5 mg/kg
) or N-(2-cyclohexyloxy-4-nitrophenyl) methanesulphonamide (a cyclooxy
genase-2 selective inhibitor) (1-100 mu g/kg) almost completely inhibi
ted the effect of VEGF (1 ng/site). Coadministration of PGE(2) (3 and
30 nmol/site) with VEGF did not restore the inhibitory effect of indom
ethacin on VEGF (1 ng/site)-induced increase in vascular permeability.
Lavendustin A (a selective tyrosine kinase inhibitor) (10 and 50 mu g
/kg, s.c.) dose-relatedly inhibited the VEGF (1 ng/site)-induced incre
ase in dye leakage, whereas its negative control, lavendustin B (10 mu
g/kg, s.c.) had no effect. Another tyrosine kinase inhibitor, geniste
in (2.5 mg/kg, s.c.) also inhibited the response. Cycloheximide (a pro
tein biosynthesis inhibitor) (35 mg/kg, s.c.) suppressed the response
of VEGF (1 ng/site). Histologically, no cellular infiltration was obse
rved in the area of VEGF injection. These results suggest that increas
ed vascular permeability induced by VEGF is mediated by local producti
on of NO and arachidonic acid metabolites other than PGE(2), which are
most probably produced by inducible NO synthase and cyclooxygenase-2,
respectively. Protein tyrosine kinase-mediated phosphorylation and sy
nthesis of any new proteins are likely to be required in this effect o
f VEGF in mouse skin.